Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Quick Take: Whats the Real Deal
In the STEP UP clinical trial, the 7.2-mg dose demonstrated a mean weight loss of 20.7% at 72 weeks, compared with a reduction of 17.5% with the previously approved semaglutide (Wegovy) injection (2.4 mg) and 2.4% with placebo
Slowed Gastric Emptying: GLP-1 slows down the rate at which food leaves the stomach and enters the small intestine
Prepare injections in a clean area, use aseptic technique, disinfect vial stoppers, and use a new sterile needle and syringe for every preparation and administration
Diabetes Injectable Alternatives: Oral GLP-1 Agonists (e.g., Rybelsus) offer the same benefits as injectables in pill form
(2023) Probability of 5% or Greater Weight Loss or BMI Reduction to Healthy Weight Among Adults With Overweight or Obesity Uchiyama, Syutaro, et al (2023) Oral Semaglutide Induces Loss of Body Fat Mass Without Affecting Muscle Mass in Patients With Type 2 Diabetes Real Science, Real Results Get expert insights on fueling your body, supporting metabolism, and living longerdelivered to your inbox every Monday
US$ 23.99
US$ 28.26
US$ 27.46
US$ 25.87
